Isotretinoin Orifarm

Isotretinoin, the active ingredient in Isotretinoin Orifarm, is a retinoid presented as an oral capsule for oral use. It treats severe recalcitrant nodular acne in patients who have not responded to other therapies.

GNH USA supplies Isotretinoin Orifarm as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isotretinoin Orifarm is a retinoid indicated for severe forms of acne that are resistant to conventional therapy. - Severe recalcitrant nodular acne: reduces inflammatory lesions and prevents formation of new nodules. - Severe acne vulgaris: decreases comedones, papules and pustules when other treatments have failed.

Isotretinoin may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dry skin: increased epidermal dryness and scaling. - Cheilitis: cracking and inflammation of the lips. - Xerosis of mucous membranes: dryness of eyes and nasal passages. - Photosensitivity: heightened skin reaction to sunlight. - Headache: mild to moderate cephalic discomfort. - Nasal bleeding: occasional epistaxis due to mucosal dryness.

Serious or Rare Side Effects: - Severe depression or suicidal ideation: mood alterations requiring immediate medical attention. - Liver enzyme elevation: hepatotoxicity detectable by laboratory monitoring. - Hypertriglyceridemia: significant rise in serum triglycerides. - Teratogenicity: risk of birth defects if exposure occurs during pregnancy. - Pseudotumor cerebri: increased intracranial pressure presenting with headache and visual changes. - Severe skin reactions: rare cases of Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before initiating therapy, several safety measures should be observed. - Pregnancy testing: confirm a negative test and maintain effective contraception throughout treatment. - Baseline labs: obtain liver function tests and lipid profile prior to start and monitor periodically. - Psychiatric monitoring: assess for depression, anxiety, or mood changes during therapy. - Avoid vitamin A supplementation: concurrent use may increase risk of toxicity. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Isotretinoin can interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Tetracyclines: concurrent use raises risk of intracranial hypertension. - Vitamin A derivatives: additive teratogenic risk. - Systemic corticosteroids: may diminish isotretinoin's therapeutic effect.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may reduce contraceptive effectiveness; consider alternative methods. - Erythromycin and other macrolide antibiotics: can increase isotretinoin plasma concentrations. - Lipid‑lowering agents: monitor triglyceride levels for additive hyperlipidaemia.